- Home
- SUPN vs SM Comparison
SUPN vs SM Comparison
Compare SUPN & SM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- SM
- Stock Information
- Founded
- SUPN 2005
- SM 1908
- Country
- SUPN United States
- SM United States
- Employees
- SUPN N/A
- SM N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- SM Oil & Gas Production
- Sector
- SUPN Health Care
- SM Energy
- Exchange
- SUPN Nasdaq
- SM Nasdaq
- Market Cap
- SUPN 2.6B
- SM 3.0B
- IPO Year
- SUPN 2012
- SM 1992
- Fundamental
- Price
- SUPN $47.92
- SM $25.17
- Analyst Decision
- SUPN Buy
- SM Hold
- Analyst Count
- SUPN 2
- SM 11
- Target Price
- SUPN $51.50
- SM $42.44
- AVG Volume (30 Days)
- SUPN 682.2K
- SM 2.2M
- Earning Date
- SUPN 11-03-2025
- SM 10-30-2025
- Dividend Yield
- SUPN N/A
- SM 3.17%
- EPS Growth
- SUPN 1411.53
- SM 1.83
- EPS
- SUPN 1.14
- SM 7.07
- Revenue
- SUPN $665,125,000.00
- SM $3,002,621,000.00
- Revenue This Year
- SUPN $6.71
- SM $33.13
- Revenue Next Year
- SUPN $19.74
- SM N/A
- P/E Ratio
- SUPN $42.23
- SM $3.57
- Revenue Growth
- SUPN 5.55
- SM 27.02
- 52 Week Low
- SUPN $29.16
- SM $19.67
- 52 Week High
- SUPN $49.66
- SM $46.42
- Technical
- Relative Strength Index (RSI)
- SUPN 66.02
- SM 43.24
- Support Level
- SUPN $47.34
- SM $24.61
- Resistance Level
- SUPN $49.66
- SM $26.41
- Average True Range (ATR)
- SUPN 1.23
- SM 1.14
- MACD
- SUPN -0.08
- SM -0.15
- Stochastic Oscillator
- SUPN 66.70
- SM 15.31
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About SM SM Energy Company
SM Energy Co is an independent energy company engaged in the acquisition, exploration, development, and production of oil, gas, and NGLs in Texas and Utah. Its portfolio is comprised of assets in the Midland Basin of West Texas, the Maverick Basin of South Texas, and the Uinta Basin of northeastern Utah.